The U.S. Food and Drug Administration (FDA) today released New and Revised Draft Q&As on Biosimilar Development and the BPCI Act (Revision 4)(1) , a sweeping guidance that codifies multiple regulatory ...
Combining tirzepatide with vitamin B12, a common additive in compounded versions of the drug, yields an impurity that could ...
A herpes zoster vaccine is safe in adults with autoimmune rheumatic disease and elicits a strong immune response, but responses are weaker in those on rituximab or mycophenolate, per a phase 4 study.
A new research paper was published in Volume 13 of Oncoscience on February 7, 2026, titled “Reduced immunogenicity of MYC amplified, metastatic prostate cancer.” ...
MYC amplification is associated with reduced tumor immunogenicity as assessed by the recovery of IR recombination reads from prostate cancer genomics ...
Scientists at The University of Texas at Austin have pulled off their clearest look yet at the Andes hantavirus, mapping the virus’s surface entry complex at near-atomic detail. That intricate ...
(OTCQX: VXRT) ("Vaxart” or the "Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced its ...
Advancing clinical development of VCN-01 for pancreatic ductal adenocarcinoma and retinoblastoma -- Licensed SYN-020 to Rasayana Therapeutics ...
Results demonstrated early signals of C-peptide preservationT1D key opinion leader, Michael J. Haller, MD, provided a recorded webinar reviewing ...
Overview of Peptide Cancer Vaccine MarketThe Global Peptide Cancer Vaccine Market is valued at USD 1.2 Billion in 2024 and is projected to reach a value of USD 15.72 Billion by 2035 at a CAGR ...
Morning Overview on MSN
Universal vaccine research advances, but a broad shot is still years away
The U.S. government and academic labs are pushing multiple universal vaccine candidates through early clinical trials, targeting influenza strains and coronaviruses that mutate faster than today’s ...
Barclays 28th Annual Global Healthcare Conference March 10, 2026 3:00 PM EDTCompany ParticipantsEmily Leproust ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results